Skip to main content
. 2015 Feb 20;8:63–79. doi: 10.2147/PGPM.S52845

Figure 3.

Figure 3

Molecular alterations in squamous cell lung carcinomas with targeted therapeutic opportunities.

Abbreviations: FGFR, fibroblast growth factor receptor; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor; PIK3, phosphatidylinositol 3-kinases; PTEN, phosphatase and tensin homolog; p53, tumor protein p53; Hsp90, heat shock protein 90; MTOR, mammalian target of rapamycin; MAPK, mitogen-activated protein kinase.